The Russian Competition Authority fines a pharmaceutical company for refusal to supply insulin (Novo Nordisk)

FAS imposed a turnover fine upon “Novo Nordisk” for refusal to supply insulin* On 15 December 2014, the Federal Antimonopoly Service (FAS Russia) found that “Novo Nordisk” Ltd. committed an administrative offence and imposed a fine

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Russian Competition Authority, The Russian Competition Authority fines a pharmaceutical company for refusal to supply insulin (Novo Nordisk), 15 December 2014, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 75691

Visites 62

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues